Skip to content
All programs presented are currently in research and development. Potential indications and applications reflect development objectives and do not represent established efficacy, safety or regulatory approval.

Legal

Cookie Policy

Last updated: 14 September 2026

01About this Cookie Policy

This Cookie Policy describes how OBNOWA PHARMA PROSTA SPÓŁKA AKCYJNA (“ObNowa Pharma”, “ObNowa”, “we”, “us”) uses cookies and similar technologies on obnowa.com.

It should be read together with our Privacy Policy.

02What are cookies?

Cookies are small text files that a website may store on your device when you visit it. Similar technologies — such as entries in your browser’s local storage or session storage — allow a website to store or access information on your device in a comparable way.

These technologies are commonly used to enable websites to function correctly and securely, to remember user preferences and, where applicable, to understand how visitors interact with a website.

03Who operates the website?

This website is operated by:

OBNOWA PHARMA PROSTA SPÓŁKA AKCYJNA,ul. Puławska 303, 02-785 Warsaw, PolandKRS: 0001254613 · NIP (Tax Identification Number): 9512653655 · REGON: 545421024Entered in the Register of Entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) maintained by the District Court for the Capital City of Warsaw in Warsaw, 13th Commercial Division of the National Court Register.

For privacy and data protection enquiries: privacy@obnowa.com.

04Cookies we use

A. Strictly Necessary Cookies

These technologies are required for the security and operation of the website, for navigation and for the management of your privacy preferences. Because the website cannot function properly without them, they may operate without optional consent where the applicable legal exemption permits this.

No analytics cookies, functional cookies or marketing / advertising cookies are currently used on obnowa.com, and no such optional technology is presented in this Policy as currently deployed. If an optional technology is introduced in the future, it will not be activated before you have given the relevant consent, and this Policy and our cookie consent tool will be updated accordingly.

05Cookie inventory

The table below reflects the technologies actually deployed on the production version of obnowa.com, verified by a technical audit of the website and its source code. The website does not set any browser cookies; it stores the following entries in your browser’s local or session storage — technologies similar to cookies.

No other cookies or similar technologies are deployed. In particular, no technology from any third-party domain is set, and no analytics, advertising, remarketing or social-media tracking technologies are implemented.

obnowa-consent

Provider
ObNowa Pharma (obnowa.com)
Purpose
Stores your cookie consent choices so that the cookie banner does not reappear on every page
Category
Strictly necessary
Duration
12 months, or until you change your choice
First-party / third-party
First-party (local storage)
Consent required
No

obnowa-intro

Provider
ObNowa Pharma (obnowa.com)
Purpose
Ensures the intro animation is displayed only once per browsing session
Category
Strictly necessary
Duration
Session only
First-party / third-party
First-party (session storage)
Consent required
No

06Legal basis

The storage of information on your device, and access to information already stored on it, is governed — where applicable — by Article 399 of the Polish Electronic Communications Law (Prawo komunikacji elektronicznej) and by the applicable EU rules, including Directive 2002/58/EC (the ePrivacy Directive).

Strictly necessary technologies may be used without optional consent where the applicable legal exemption permits this. Non-essential cookies or similar technologies that require consent are never activated before valid consent has been obtained.

Where the use of cookies or similar technologies involves the processing of personal data, Regulation (EU) 2016/679 (GDPR) and the Polish Act of 10 May 2018 on the Protection of Personal Data apply to that processing, as described in our Privacy Policy.

07Cookie consent

When you first visit obnowa.com, our cookie consent tool allows you to: accept all optional cookies; reject all optional cookies; or manage your preferences by category. No optional cookie category is ever pre-selected.

Rejecting optional cookies is as easy and as prominent as accepting them, and no optional cookie or similar technology loads before your consent has been recorded.

We never treat inactivity, scrolling, closing the banner or continued browsing of the website as consent.

08Changing or withdrawing consent

You can change or withdraw your consent at any time through the “Cookie Settings” link, which is permanently available in the footer of every page of this website. Withdrawing consent is as easy as giving it.

Once consent is withdrawn, the relevant optional technologies are not used subsequently. Withdrawal does not affect the lawfulness of any use that took place before consent was withdrawn.

09Browser settings

You may additionally control cookies and similar technologies through your browser settings — for example by blocking or deleting them. Please note that blocking strictly necessary technologies may affect the operation of obnowa.com, and certain website functions may not work correctly.

10Changes to this Cookie Policy

We may update this Cookie Policy following changes in law, technology or website functionality. The current version will always be published on this page, and the date of the latest update is shown at the top of this Policy.

11Contact

For any question about this Cookie Policy or the technologies used on obnowa.com, contact us at privacy@obnowa.com.

ObNowa Pharma

ObNowa Pharma is a global pharmaceutical development company headquartered in Warsaw, Poland. We combine science, pharmaceutical innovation and rigorous clinical development, focusing on solutions that matter to patients and physicians. Our portfolio spans two complementary areas: hair growth and neurotoxin-based medical aesthetics.

Warsaw · Poland · EU

Enquiries

Development status

All programs presented are currently in research and development. Potential indications and applications reflect development objectives and do not represent established efficacy, safety or regulatory approval.

© 2026 ObNowa Pharma Prosta Spółka Akcyjna. All rights reserved.